Life Sciences & Health

The Life Sciences & Health cluster in Brabant is a comprehensive and lively ecosystem that includes specialist research, sophisticated production capability and willing investment capital. Judged by volumes of patent applications, the number of start-ups boldly finding commercial viability and the way local health corporates lead their sectors in world markets, Brabant is well on its way to achieving status as a globally recognised health cluster.

Philips ambient cathlab061023 28 km

Brabant. strong physical presence.

Especially strong in pharma, biotech, medical technology and animal health, with ties in agrifood, Brabant broadens your collaboration options with extensive eco-systems comprising global life sciences industry leaders interwoven with world renowned knowledge institutes and public organizations. This high concentration of innovation means you can tap into a rich supply of high-tech medical applications, including eye surgery robots and wearable healthcare.

Liefe sciences and health image
Bambimedical eindhoven petervantrijen 1464

Bright business

Brabant hosts a large number of international life sciences & health companies and a high density of OEM’s – including Philips, MSD, Amgen, Abbott Labs, Jansen Cilag – that are leading in many different technologies. Moreover, start-ups such as Xeltis (biodegradable heart valves), Bambi Medical (monitoring pads) and Aduro (cancer drugs) all operate from Brabant as well.

Read more
Laboratory Lievensberg in Bergen op Zoom

Bright people

Keeping your company up to date with the endless stream of new technologies can be tough, so access to new talent is a must! In Brabant, 18,500 people are working in Life Sciences & Health. Within this group 45% has a higher education and 34% has a medium education, meaning that 5,000 highly educated people are active in this industry. Each year, more than 2000 students graduate from the Life Sciences & Health programs of our local universities.

Read more

The core discovery and research capabilities supporting our original platform are driven from Oss in the Netherlands, reflecting a further investment in our antibody programs. Our collaboration with Merck is great news for European biotech and research in immuno-oncology.

Hans van Eenennaam, Executive Vice President - Aduro

More information?

Contact our specialist

[email protected]
+31 (0)6 14 60 05 14
Thijs Taminiau BOM

Thijs Taminiau

Teamleader foreign investments Agrifood

First name
Last name
Email address
Phone number
Question / remarks